# Dr. Luli Akinfiresoye

Type: Person

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/dr-luli-akinfiresoye
Canonical HTML page: https://getlegalbrief.com/entity/dr-luli-akinfiresoye

## Timeline

- **2026-08-17**: Post-Hearing Briefs Due — Parties submit final briefs to Administrative Law Judge Derek C. Julius, summarizing their arguments on the evidentiary record and legal standards. The recommendation on rescheduling is expected to follow shortly thereafter.
- **2026-07-08**: Rescheduling Hearing Testimony — Under subpoena, Dr. Akinfiresoye testifies in the marijuana rescheduling proceeding that marijuana fails the first three factors of the DEA's five-factor test, directly contradicting the HHS Schedule III recommendation.
- **2024**: DEA Scientific Data Review Published — Dr. Luli Akinfiresoye authors the DEA's internal Scientific Data Review on marijuana, reportedly concluding that marijuana lacks sufficient, reproducible scientific evidence for accepted medical use.

## Recent coverage (2 stories)

### DEA's 5-Part Medical-Use Test Under Fire as Marijuana Rescheduling Hearing Heads to August 17 Briefs
2026-08-10 03:18:11 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

ALJ Julius's upcoming recommendation in the DEA marijuana rescheduling hearing may challenge the government's novel approach of limiting Schedule III status to state-licensed medical programs, after DEA scientist testimony cast doubt on whether such programs satisfy the Controlled Substances Act's rigorous medical-use standard.
Full story: https://getlegalbrief.com/story/dea-marijuana-rescheduling-legal-tensions

### DEA's Own Expert: Marijuana Fails 3 of 5 Medical Use Factors—Order at Risk
2026-07-27 07:23:59 · Sentiment: Bearish · Impact: 6/10 · Sources: 2

DEA pharmacologist Dr. Luli Akinfiresoye testified that marijuana fails the agency's historical scientific standard for accepted medical use, directly contradicting the HHS recommendation to reschedule. This intra-agency conflict exposes the proposed Schedule III rule to a likely arbitrary-and-capricious challenge, redefining the evidentiary landscape for controlled substance rulemaking.
Full story: https://getlegalbrief.com/story/dea-expert-marijuana-fails-medical-use-test-legal-challenge

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.